Dynamic leader / Innovative problem solver experienced in multi-disciplinary scientific planning & execution with ability to synergize personnel with diverse backgrounds, develop business strategies and manage relationship with various constituents. Initiated research projects, led product development / validation and delivered FDA-approved diagnostic products. Managed - Collaboration with top academic Key Opinion Leaders (KOLs, 20+ from over a dozen academic institutions) - Collaboration with major pharmaceutical companies (5 of top 10 oncology pharmas) with preclinical studies and clinical trials - Publications, presentations and IP filing. Skilled in performing enterprise valuation and forecasting / strategic positioning in competitive environments. Performed market research, developed business strategies, wrote business plans and raised funds. Specialties: INNOVATIVE BIOTECH RESEARCH / PRODUCT DEVELOPMENT & LAUNCHING / BUSINESS DEVELOPMENT/ STRATEGIC PLANNING, COLLABORATION & NEGOTIATION / START-UP & LARGE COMPANY EXPERIENCE

Sr. Director, Research & Development @ Senior Scientist I/ II, Associate Director, Director (2006 – 2012) Research / Development & Science Strategy Management in Oncology / Targeted Therapy / Personalized Medicine Clinical Study Management, KOL / Collaboration / Relationship Management Created an Ultra Sensitive Proteomic Microarray based technology to profile disease states and monitor therapy progress. Strategic planning and technology development experience: * Technical Project Management * Advance Technology Evaluation * Patent Search and Patent Filing * Development of External Research Collaboration Support Business Development Publication Management From May 2006 to Present (9 years 6 months) Greater San Diego AreaDirector, R & D @ Effectively addressed and engaged a wide variety of audiences—from benchtop scientists, project leaders, and top management officers to potential business partners and investors. Promoted comprehensive organizational goals and ambitions and negotiated achievable “actions and follow ups.” Managed and directed corps of scientists and engineers for various projects at different stages in cGMP environment. Prepared and submitted FDA 510(k) applications and obtained FDA approvals. Established and managed external corporate and academic scientific collaborations. Interacted extensively with business development and marketing projects. Developed a fully automated seamless BioFilm-based microarray diagnostic system/ application for mutation and SNP / STR detection and analysis. Developed an innovative Forensic STR Analysis utilizing INFINITITM Microarray Techonology and RNase H mediated Discrimination – * US Patent Pending Technology. From February 2003 to April 2006 (3 years 3 months) President & CEO @ Started this corporation focusing on disseminating genetics information to academic, clinical, and general public audiences through the virtual community. Successfully developed nanotechnology based molecular diagnostic tools/assays. Raised capital funds (Angel, VC, grants & contracts). Corporate planning, research and daily business operations. Established multiple strategic alliances with academic and industrial partners. Established a genetic information Web site for the lay public, clinicians and researchers Chief editor and publisher for KnowledGENE Online Journal Appointed Assistant Professor, Keck School of Medicine, Department of Pediatrics, University of Southern California, CA From May 1999 to December 2002 (3 years 8 months) Research Scientist @ Characterization of diphtheria toxin. Developed a quantitative nuclease activity assay using radio isotopes. From September 1991 to June 1994 (2 years 10 months)

MBA @ University of Southern California - Marshall School of Business From 2007 to 2009 Post-Doc, Human Genetics @ David Geffen School of Medicine at UCLA From 2000 to 2002 Ph.D., MIMG - Microbiology, Immunology and Molecular Genetics @ University of California, Los Angeles From 1994 to 2000 B.S., Biochemistry @ University of California, Los Angeles From 1987 to 1991 PHILLIP MBA. is skilled in: Biotechnology, Lifesciences, Medical Devices, Molecular Biology, Oncology, Commercialization, Genomics, FDA, Technology Transfer, R&D, Biochemistry, Genetics, Product Development, Immunology, Pharmaceutical Industry, Assay Development, Drug Discovery, Cross-functional Team..., GMP, Cancer, Biopharmaceuticals, Clinical Development, Cell, Cell Biology, Cell Culture, Clinical Trials, Drug Development, Infectious Diseases, Start-ups, Validation, Biomarker Discovery, Microbiology, Proteomics, Life Sciences